These compounds may interact with:
Tyrosine-protein phosphatase non-receptor type 1
Potentially involved in: carcinoma; crohn's disease; diabetes mellitus; obesity; cancer; hyperglycemia; diabetes mellitus, non-insulin-dependent; hodgkin disease; insulin resistance; liver cirrhosis, experimental; mediastinal neoplasms; rett syndrome; schizophrenia; b-cell lymphomas; diabetes mellitus, noninsulin-dependent; lung cancer; ovarian cancer; diabetes mellitus, type 2; hyperinsulinism; hypertension
Disease data sourced from Pharos.